BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10974610)

  • 1. Olanzapine and obsessive-compulsive symptoms.
    Lykouras L; Zervas IM; Gournellis R; Malliori M; Rabavilas A
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):385-7. PubMed ID: 10974610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
    de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
    J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of compulsive symptoms with olanzapine treatment.
    Mahendran R
    Aust N Z J Psychiatry; 2002 Aug; 36(4):565. PubMed ID: 12169167
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 5. Worsening of obsessive-compulsive symptoms following treatment with olanzapine.
    Morrison D; Clark D; Goldfarb E; McCoy L
    Am J Psychiatry; 1998 Jun; 155(6):855. PubMed ID: 9619164
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive symptoms with olanzapine.
    Alevizos B; Papageorgiou C; Christodoulou GN
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):375-7. PubMed ID: 15231024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provocation of obsessive-compulsive behaviour and tremor by olanzapine.
    al-Mulhim A; Atwal S; Coupland NJ
    Can J Psychiatry; 1998 Aug; 43(6):645. PubMed ID: 9729696
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia.
    Kulkarni G; Narayanaswamy JC; Math SB
    Indian J Pharmacol; 2012; 44(5):649-50. PubMed ID: 23112432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.
    Poyurovsky M; Dorfman-Etrog P; Hermesh H; Munitz H; Tollefson GD; Weizman A
    Int Clin Psychopharmacol; 2000 May; 15(3):169-73. PubMed ID: 10870875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
    Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
    J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
    Safranko I
    Aust N Z J Psychiatry; 2003 Feb; 37(1):112. PubMed ID: 12534671
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder.
    Jonkers F; De Haan L
    Psychopharmacology (Berl); 2002 Jun; 162(1):87-8. PubMed ID: 12107623
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
    Ramasubbu R; Ravindran A; Lapierre Y
    Pharmacopsychiatry; 2000 Nov; 33(6):236-8. PubMed ID: 11147933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradox of quetiapine in obsessive-compulsive disorder.
    Tranulis C; Potvin S; Gourgue M; Leblanc G; Mancini-Marie A; Stip E
    CNS Spectr; 2005 May; 10(5):356-61. PubMed ID: 15858452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder.
    Marusic A; Farmer A
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G
    Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.